Latest news
Lilly beats forecasts as Mounjaro, Zepbound drive 48% revenue surge - The Pharma LetterThe Pharma Letter · Thu, 06 Aug 2026 11:50:30 GMTLilly's Mounjaro, Zepbound sales surge, widening lead over Novo Nordisk - ET PharmaET Pharma · Thu, 06 Aug 2026 00:21:33 GMTLilly beats estimates on resilient demand for injectable GLP-1 drugs, widens gap with Novo - ReutersReuters · Wed, 05 Aug 2026 17:51:09 GMTEli Lilly Shares Surge 6% On Upbeat Annual Earnings Forecast; Mounjaro Sales Spike 91% - NDTV ProfitNDTV Profit · Wed, 05 Aug 2026 13:36:59 GMTEli Lilly Posts Higher Revenue on Continued GLP-1 Demand - WSJWSJ · Wed, 05 Aug 2026 11:19:00 GMTEli Lilly easily tops quarterly estimates, raises outlook as Zepbound and Mounjaro sales surge - CNBCCNBC · Wed, 05 Aug 2026 10:45:42 GMTSouth Korea to flag Wegovy, Mounjaro for abuse as sales surge - KED GlobalKED Global · Mon, 03 Aug 2026 13:31:12 GMT